Add BrightSurf on Google Email

Institute for Research in Biomedicine (IRB Barcelona)


The climate crisis could trigger the outbreak of new and lethal infectious diseases

A team from IRB Barcelona identifies Candida orthopsilosis, a hybrid fungus, as a potential pathogen that could infect humans and cause disease. The study suggests that climate change may have facilitated the emergence of this new microorganism, which has already been linked to several outbreaks and fatalities.

Development of new p38 protein inhibitors with therapeutic potential for some heart diseases

Researchers at IRB Barcelona have developed new p38 inhibitors that selectively impair one of the activation pathways of the protein, allowing it to perform many of its normal functions. The inhibitors show therapeutic potential for heart diseases such as cardiac cell death and cardiotoxicity.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Communications·TypeExperimental study·DateJul 13, 2023

The structure of a protein bound to DNA reveals how the toxicity of the cholera bacterium is activated

The study of ToxR's protein structure bound to DNA has revealed how it triggers cholera toxin production. The research provides insights into the molecular mechanism behind Vibrio cholerae's virulence, shedding light on potential treatments for this disease.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJul 11, 2023

Scientists unveil the mechanism behind intracellular connection: mitofusin 2 is the lock and key

Researchers discovered distinct variants of the mitochondrial protein Mitofusin 2, ERMIT2 and ERMIN2, located on the endoplasmic reticulum, forming a bridge between mitochondria and this organelle. These variants play a crucial role in maintaining optimal cellular functionality and regulating lipid metabolism.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalScience·TypeExperimental study·DateJun 28, 2023

A new model predicts the flexibility of DNA movement at the molecular scale

A new model of DNA flexibility has been developed, providing results of unprecedented quality and characterizing precision and efficiency at the computational level. The study presents a systematic and comprehensive analysis of DNA movement correlations and introduces a new method to capture them.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNucleic Acids Research·TypeComputational simulation/modeling·DateMar 31, 2023

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

A study published in Nature Communications reveals that platinum accumulates in healthy cells surrounding cancer cells, particularly fibroblasts, and induces gene activation associated with poor response to chemotherapy. Periostin levels serve as a marker of TGF-β activity in fibroblasts and predict treatment benefit.

Scientists at IRB Barcelona and the PCCB develop a study model for Ewing sarcoma in the Drosophila fly

Scientists at IRB Barcelona and the PCCB have created a genetically tractable model of Ewing sarcoma using Drosophila flies expressing a mutant version of the human oncogene EWS-FLI. This model allows for the identification of critical proteins required for EWS-FLI's oncogenic function and potential therapeutic targets.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalPNAS Nexus·TypeExperimental study·DateOct 7, 2022

Cancer research repurposed to expose age-related blood diseases

Scientists at IRB Barcelona develop a new approach to pinpointing the genes driving clonal hematopoiesis, a biological process linked to ageing and increased risk of blood malignancies. By adapting cancer genomics tools, researchers aim to improve early detection and monitoring of this condition.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Communications·TypeComputational simulation/modeling·DateAug 2, 2022

Not individual genes but the “mutational signatures” of many genes hold the key to better cancer therapies

Researchers have found that mutational signatures, which reflect a collection of mutations across the genome, can accurately predict drug response in cancer cells. The study suggests that these signatures may hold the key to better cancer therapies and could be used to predict treatment response.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Communications·TypeComputational simulation/modeling·DateMay 26, 2022

An international consortium, led by IRB Barcelona and the biotechnology company Merus, reports the discovery of MCLA-158, the first clinical candidate screened in organoids targeting cancer stem cells of solid tumors

Researchers from IRB Barcelona and Merus have discovered MCLA-158, a bi-specific antibody targeting cancer stem cells. The treatment prevents metastasis and slows primary tumor growth in experimental models of cancer.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Cancer·TypeExperimental study·DateApr 25, 2022

RNA molecules with no apparent function represent a new therapeutic approach against fungal infection by Candida

Researchers have identified fragments of genetic material in Candida fungus that do not encode proteins but are specifically expressed during distinct stages of the infection process. These long non-coding RNA molecules show high specificity and differ between species, making them a potential target for new treatments.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Communications·TypeExperimental study·DateDec 16, 2021

One mutation or two? Researchers in Spain discover why some genes require one or two hits to promote cancer

A study by Spanish researchers has deciphered the landscape of third-order interactions in cancer, revealing that many genes involved in cancer may require one or two hits depending on other mutations. This discovery opens the way to more precise genetic diagnosis and new therapeutic targets.

Spanish scientists determine the mode of action of essential proteins involved in cancer and Alzheimer´s disease

Researchers have discovered that specific regions of HAT family proteins determine which amino acids they bind to, leading to unique functions in cell growth and diseases like cancer and neurodegenerative disorders. This knowledge will enable efforts to develop compounds targeting these proteins for therapy.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalProceedings of the National Academy of Sciences·DateNov 29, 2021

Palmitic acid promotes cancer metastasis and leaves a more aggressive “memory” in tumour cells

A diet rich in palmitic acid makes tumor cells more aggressive and increases their metastatic capacity, a process that is responsible for 90% of cancer deaths. Exposure to palmitic acid leads to permanent epigenetic modifications in tumor cells, allowing them to conserve metastatic capacity even after the fatty acid is removed.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature·TypeExperimental study·DateNov 10, 2021

Centriole instability might contribute to some cases of microcephaly

Researchers at IRB Barcelona have identified γTuRC as a centriole stabilizer, revealing its role in maintaining centriole stability and preventing microcephaly. The study's findings suggest that defects in γTuRC may contribute to various human diseases, including adolescent scoliosis and male infertility.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Communications·TypeExperimental study·DateNov 1, 2021

Four commonly used medications reverse Alzheimer's disease in mice

Researchers have found four commonly used medications that can reverse Alzheimer's disease in mice by addressing the underlying causes of the condition. The study identifies non-steroidal anti-inflammatories and anti-hypertensives as effective treatments, paving the way for early diagnosis and potential therapy.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalGenome Medicine·TypeExperimental study·DateOct 27, 2021

Identification of genes that cause resistance to treatment of the pathogenic fungus Candida

Researchers have identified eight genes in the Candida glabrata fungus that confer resistance to various drugs. The study allows for genetic testing to diagnose potential drug resistance, guiding treatment choices. The findings also highlight cross-resistance phenomena, where exposure to one drug can lead to resistance to another.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalCurrent Biology·TypeComputational simulation/modeling·DateOct 25, 2021

A new method to understand protein dynamics 
and the regulation of cellular processes’

Researchers developed a new computational procedure to discover functional protein shapes, revealing molecular details of cellular processes. The approach focused on allosteric regulation and applied to adenylate cyclase, a key enzyme in energy metabolism and hormone signaling.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalScience Advances·TypeComputational simulation/modeling·DateSep 9, 2021

To die or not to die in response to stress, a decision regulated by MK2 protein levels

The study reveals that MK2 protein levels act as a molecular indicator for cell survival or death, with higher levels associated with cell death and lower levels linked to survival. Moderate stress triggers temporary activation of the p38-MK2 pathway, allowing cells to recover.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalProceedings of the National Academy of Sciences·DateJul 19, 2021

Deep machine learning completes information about the bioactivity of one million molecules

Researchers have developed a tool to predict the biological activity of any molecule using deep machine learning methods. The system integrates experimental data with AI models to complete incomplete information about bioactivity profiles, enabling the selection of suitable candidates for drug discovery.